Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 11,657

Document Document Title
WO/2017/206026A1
Disclosed are a composition and use thereof, the composition comprising the following components in parts by weight: 1 to 500 parts o f astaxanthin; 1 to 1000 parts of a potassium salt; 1 to 500 parts of a calcium salt; 1 to 500 parts of...  
WO/2017/208172A1
The present invention relates to a composition for use as a medicament, in the form of a gel with characteristics of a reversible thermogel, based on one or more poloxamers, water and optionally excipients, and an effective amount of an ...  
WO/2017/206105A1
An edible composition comprising an insoluble fiber and a prebiotic and liquid-absorbable gel can reduce the digestion or absorption of the harmful/toxic substance existed in food or drink.  
WO/2017/209934A1
An autophagy activator, such as vitamin D, for use in a method of treating or preventing skin damage in a subject in need thereof is described, that includes administering to the subject a therapeutically effective amount of said activat...  
WO/2017/204619A1
The present invention provides an aqueous extract of Andrographis paniculata leaves containing as main components andrographolide, neoandrographolide and 14-deoxy-11,12-didehydroandrographolide. The Invention also provides a method of pr...  
WO/2017/197793A1
A life-prolonging liquor, consisting of the components of: 10 g of Herba Cistanche, 20 g of Radix Rehmanniae, 10 g of Radix Rehmanniae Preparata, 10 g of Radix Asparagi, 10 g of Radix Ophiopogonis, 20 g of Radix Angelicae Sinensis, 10 g ...  
WO/2017/199073A1
An oral pharmaceutical formulation for effervescent tablet of deferiprone is reported comprising of deferiprone and a taste-masking composition consisting of an effective amount of sweetener and flavoring agent and containing appropriate...  
WO/2017/197781A1
The present invention provides a health-care and body-strengthening Fructus Lycii liquor, comprising the following components: Fructus Lycii: 50 g; Flos Chrysanthemi: 50 g; Radix Rehmanniae Preparata: 45 g; stir-baked Massa Medicata Ferm...  
WO/2017/195359A1
This hop processed product for suppressing fat accumulation or for antioxidation contains greater than or equal to 50 wt%, preferably greater than or equal to 60 wt%, and most preferably greater than or equal to 70%, of hop flowers (E・...  
WO/2017/193458A1
Disclosed are an organosilicone modified acrylic polyester potassium salt and a preparation method therefor. The organosilicone modified acrylic polyester potassium salt is prepared from an acrylic acid or esters thereof, acrylic organos...  
WO/2017/192581A1
Provided herein are methods for treating a subject in need of such treatment comprising administering a therapeutically effective amount of one or more pharmaceutical compositions comprising a 1,2-HOPO chelating agent and/or a 3,2-HOPO c...  
WO/2017/185280A1
Disclosed are a biological compound preparation which can improve altitude hypoxia tolerance and a preparation method thereof, comprising the raw materials by weight: 2-10 parts of folium ginkgo extract, 5-15 parts of guarana extract, 10...  
WO/2017/180591A1
The invention provides nanozymes that accumulate in the kidney and methods for their use.  
WO/2017/174744A1
A delivery system comprising hydrogen peroxide or a hydrogen peroxide generator system, for use in a method for the treatment or prevention of inflammatory bowel disease in a mammal, is described. The method comprises a step of orally ad...  
WO/2017/170762A1
The purpose of the present invention is to provide a tablet having sufficient strength and containing spherical adsorptive carbon for oral administration. This purpose is met with a tablet that contains spherical adsorptive carbon for or...  
WO/2017/170764A1
The purpose of the present invention is to provide a tablet, and a production method thereof, which has a high absorption rate of spherical adsorptive carbon for oral administration, and a high uniformity of the spherical adsorptive carb...  
WO/2017/169652A1
The method for producing polyphenols according to one embodiment of the present invention comprises a step for mixing used tea leaves with water to generate a liquid mixture. The liquid mixture is heated. From the heated liquid mixture, ...  
WO/2017/160864A1
The present invention includes a method of protecting or treating neural cells from degeneration comprising: identifying a neural cell in need of protection from at least one of radical oxidative stress, increased mitochondrial biogenesi...  
WO/2017/160864A8
The present invention includes a method of protecting or treating neural cells from degeneration comprising: identifying a neural cell in need of protection from at least one of radical oxidative stress, increased mitochondrial biogenesi...  
WO/2017/158041A1
The present invention relates to compositions comprising at least one film- forming agent able to adhere in a stable way to the mucosa of the mouth, esophagus and upper airways, establishing a mechanical form of protection against attack...  
WO/2017/159554A1
The invention provides a crystal of glutathione having excellent flowability and pulverizability, and a method for producing the same. The invention relates to a crystal of reduced-form glutathione, wherein the average crystal thickness ...  
WO/2017/159555A1
The purpose of the invention is to provide: a crystal of reduced-form glutathione in which the content of impurities, particularly L-cysteinyl-L-glycine, is reduced; and a method for producing the same. The invention relates to a crystal...  
WO/2017/157350A1
An edaravone dosage form and a use thereof in preparing a drug used for treating diseases related to oxidative stress, the dosage form being selected from a lipid-based delivery system, a solid dispersion, micelles and a solubilising age...  
WO/2017/152237A1
The present invention relates to new Desferrioxamine B-based compounds that are useful for iron-chelation therapy, to their preparation, and to compositions including the compounds. The present invention also relates to the use of the co...  
WO/2017/152718A1
Disclosed are an injection comprising chlorine dioxide for use in the therapeutic goals of promoting the regeneration of stem cells in vivo, and being anti-tumour and anti-ageing, etc., and a preparation method therefor. The injection ha...  
WO/2017/150409A1
Provided is a cacao extract with better flavor and in which off-flavor is suppressed, and a method for manufacturing such a cacao extract. The cacao water extract of the present invention contains polyphenol. In this cacao water extract,...  
WO/2017/152114A1
A tumescent contravenom solution including: (a) a vasoconstrictor, (b) a physiological crystalloid solution, and (c) optionally a contravenom agent that neutralizes tissue toxic enzymes present in a venom and/or a drug that impairs or pa...  
WO/2017/148183A1
Disclosed are a compound traditional Chinese medicine composition containing gynostemma pentaphyllum and a preparation method thereof. The compound traditional Chinese medicine composition containing gynostemma pentaphyllum is made of gy...  
WO/2017/147505A1
Provided are methods of treating muscle and liver disorders, and for increasing mitochondrial mass and/or functionality in a mammalian myocyte and/or hepatocyte.  
WO/2017/147263A1
The present invention relates to an isolated recombinant human lipidated survivin expressed in an Escherichia coli-based system. The isolated recombinant human lipidated survivin augments the expression levels of costimulatory molecules ...  
WO/2017/147522A1
The present disclosure relates to solutions and methods of preparing lyophilized formulations of factor Xa (fXa) antidotes. A suitable aqueous formulation suitable for lyophilization can include a fXa antidote, a solubilizing agent, and ...  
WO/2017/142388A3
The present invention relates to a specific mixture of hybrid proteins formed with toxins selected from the venom of scorpions from different parts of the world and thioredoxin protein, which are expressed heterologously, by means of gen...  
WO/2017/142961A1
The present invention provides a method for treating neurodegenerative disease, traumatic brain injury, or stroke. In particular, the present invention provides a method for using a glycopeptide PACAP/VIP analogues with enhanced CNS pene...  
WO/2017/138626A1
A nerve growth promoter and an antioxidant containing a digested product obtained by using a protease to digest a composition containing hyaluronic acid and a protein. A wound treatment agent containing an ethyl acetate extract from a di...  
WO/2017/135286A1
Provided are an urolithins-containing aqueous solution comprising urolithins and collagen, a dried solid composition thereof, and a production method therefor, and an urolithins stabilizing method.  
WO/2017/133037A1
A health care liquid capable of enhancing human immunity and resisting against ageing comprises, by mass percent, 30% to 60% of original plant juice, 3% to 8% of wine bases, 0 to 15% of auxiliary materials and the balance water. The orig...  
WO/2017/135466A1
The present invention relates to a novel composition containing xanthophyll, or a salt thereof, and a processed product of a Trapa genus plant, and to a novel ophthalmic composition containing a processed product of a Trapa genus plant. ...  
WO/2017/129132A1
Provided is a healthcare hot compress Chinese medicine bag comprising a Chinese medicine composition and a pharmaceutical bag for packaging the Chinese medicine. The Chinese medicine composition is made from the following components by w...  
WO/2017/130709A1
One solid preparation of the present invention has fine silicon particles as a principal component thereof, and exhibits a hydrogen generation capacity. In addition, one embodiment of this solid preparation has fine silicon particles whi...  
WO/2017/131127A1
Provided are: a novel bisphosphonic acid compound which exhibits prominent inhibitory activity against ectopic calcification, or a salt thereof; and a pharmaceutical composition containing the compound or salt thereof. The bisphosphonic ...  
WO/2017/125080A1
Provided is an application of a fullerene / metal-fullerene micro/nanomaterial for preparing a pharmaceutical product. The pharmaceutical product has at least one of the following properties: 1) treats a bone marrow suppression; 2) treat...  
WO/2017/125498A1
The ratio of the metals zincand cadmium is of great significance for error-free proliferation and differentiation of cells. An understanding of the role of cadmium in the etiology of cancer offers possibilities to gain a better understan...  
WO/2017/126708A1
The purpose of the present invention is to provide a prophylactic or therapeutic agent for oxidative stress damages, which is intended to be administered during phacoemulsification and aspiration for cataract. The present invention is a ...  
WO/2017/124921A1
The present invention provides a walnut oligopeptide powder, and a preparation method and application thereof. The oligopeptide powder has a peptide content of 80 wt% or higher, wherein 95% or more of the peptides have a molecular weight...  
WO/2017/122120A1
Methods, formulations and kits for treating and/or protecting against acute liver failure and other hepatotoxicities in an individual employ a combination of a first active agent which replenishes, or decreases a loss of, functional glut...  
WO/2017/123823A1
This application discloses compounds and pharmaceutical compositions and methods of using the same for inhibition of sulfide:quinone oxidoreductase (SQOR).  
WO/2017/114992A1
The invention relates to a method for producing an extract containing hydroxycinnamic acids, characterised in that the method uses one or more vegetable waste products from the production of vegetable food products as a raw material, and...  
WO/2017/115705A1
[Problem] To provide a medicinal composition that is capable of improving the prognosis after the restart of the patient's own heartbeat even after the passage of a considerably long period of time after the restart of the patient's own ...  
WO/2017/107628A1
The present disclosure belongs to the technical field of pharmaceutical preparations and specifically relates to a chitosan oligosaccharide capsule and method for preparation thereof. The chitosan oligosaccharide capsule comprises conten...  
WO/2017/101793A1
The invention belongs to the field of biomedical research involving the 1, 3, 4- selenyldiazo derivatives that have cell protective activity. Because there are not so many heterocyclic selenium compounds, we synthesized a new type of sel...  

Matches 1 - 50 out of 11,657